Here, we provided the first evidence that DDX39B protein expression was gradually upregulated from paracancerous tissue to primary tumor tissue to metastatic NSCLC tissue and that elevated DDX39B protein level was an independent indicator of poor overall survival in patients with NSCLC. This evidence concerns the gene DDX39B and neoplasm.